Skip to Main Content
Legislation Search

S. 1098: Opioid Overdose Data Collection Enhancement Act

This bill, titled the Opioid Overdose Data Collection Enhancement Act, aims to improve the ways in which data related to opioid overdoses is collected and shared across various states and localities. Here are the key components of the bill:

Purpose

The primary goal of the bill is to enhance the collection and interoperability of data concerning both fatal and nonfatal overdoses. This will be achieved through the development and implementation of a web-based, mobile-friendly software platform that allows for near real-time tracking of these incidents, as well as the use and administration of opioid overdose reversal medications.

Comprehensive Opioid Abuse Grant Program

The bill amends existing legislation by establishing a specific program for overdose data collection under the Comprehensive Opioid Abuse Grant Program. Here are the main elements:

Overdose Data Collection Program

States, local governments, law enforcement coalitions, and Indian tribes are encouraged to develop and implement data collection tools, including mobile mapping applications, that enable them to quickly and efficiently track:

  • Locations of suspected fatal and nonfatal overdoses
  • Administration of opioid overdose reversal medication by first responders

Eligibility for Grants

Coalitions of law enforcement agencies can apply for grants specifically aimed at implementing overdose data collection programs. They will have to meet the same requirements as states and local governments.

Requirements for Implementation

Those implementing the overdose data collection program must:

  • Support coordinated public safety and health responses based on collected data
  • Focus on areas where overdose occurrences and concerning trends are identified
  • Ensure compatibility with existing overdose data tools at various government levels
  • Make the data accessible to relevant governmental and law enforcement bodies

Audit and Application Process

Entities applying for grants must conduct an audit of current data and resources related to overdose collection before submitting their applications, ensuring that they do not duplicate existing resources.

Consultation with Agencies

The Attorney General is tasked with consulting relevant agency heads as part of implementing the overdose data collection program to ensure adequate support and integration of efforts.

Relevant Companies

  • ABBV: As a pharmaceutical company that focuses on drug development, ABBV could be involved in the supply of overdose reversal medications, potentially impacting their market strategies and focus on opioid-related solutions.
  • PFE: Pfizer is a major pharmaceutical company that produces medications for a variety of health issues, including pain management and possibly overdose treatments. Changes in opioid legislation may influence their product offerings and marketing strategies.
  • AMGN: Amgen, which also has a stake in the development of medicinal therapies, may find its product lines or research interests affected by increased data collection and possible regulatory changes in the opioids space.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

4 bill sponsors

Actions

2 actions

Date Action
Mar. 24, 2025 Introduced in Senate
Mar. 24, 2025 Read twice and referred to the Committee on the Judiciary.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Dwight Evans D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
Apr 17, 2025 Apr 03, 2025 -12.13%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Apr 07, 2025 Mar 31, 2025 -6.79%
Congress pfp
Marjorie Taylor Greene R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 19, 2025 Mar 17, 2025 -12.15%
Congress pfp
Carol D. Miller R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Apr 11, 2025 Mar 10, 2025 -10.76%
Congress pfp
Bruce Westerman R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -5.78%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 26, 2025 -4.70%
Congress pfp
Robert Bresnahan R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 27, 2025 Feb 25, 2025 -5.76%
Congress pfp
Robert Bresnahan R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 -3.82%
Congress pfp
Jefferson Shreve R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -5.04%
Congress pfp
Jefferson Shreve R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $50,001 - $100,000
Mar 09, 2025 Feb 24, 2025 -3.35%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 +1.41%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 +0.04%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Mar 12, 2025 Feb 12, 2025 -0.29%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 24, 2025 -1.70%
Congress pfp
Julie Johnson D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Feb 12, 2025 Jan 15, 2025 -4.34%
Congress pfp
Jared Moskowitz D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +12.18%
Congress pfp
Jared Moskowitz D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 +12.18%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +18.86%
Congress pfp
Virginia Foxx R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +11.59%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +15.13%
Congress pfp
Marjorie Taylor Greene R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Nov 21, 2024 Nov 20, 2024 +13.99%
Congress pfp
Laurel M. Lee R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $15,001 - $50,000
Nov 21, 2024 Oct 21, 2024 -13.66%
Congress pfp
Greg Landsman D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Nov 14, 2024 Oct 15, 2024 -15.59%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -10.17%
Congress pfp
John James R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -7.77%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Sep 04, 2024 Aug 09, 2024 -21.24%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -12.80%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $15,001 - $50,000
Aug 20, 2024 Aug 06, 2024 -25.31%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -15.75%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 20, 2024 Aug 01, 2024 -24.73%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 +8.32%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -6.68%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $15,001 - $50,000
Jun 14, 2024 May 03, 2024 -23.35%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Sale $1,001 - $15,000
May 02, 2024 Apr 10, 2024 -0.04%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Purchase $1,001 - $15,000
May 15, 2024 Apr 03, 2024 -3.82%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 04, 2024 -17.25%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -19.38%
Congress pfp
Roger Williams R / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Jun 12, 2024 Mar 01, 2024 -19.38%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Mar 15, 2024 Feb 27, 2024 -21.52%
Congress pfp
Earl Blumenauer D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Purchase $1,001 - $15,000
Mar 02, 2024 Feb 12, 2024 -25.05%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -19.12%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -5.31%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Sale (Full) $1,001 - $15,000
Feb 14, 2024 Jan 19, 2024 -4.17%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -19.08%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -18.25%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -33.59%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 22, 2024 Dec 28, 2023 -33.59%
Congress pfp
John Boozman R / Senate
PFE logo
PFE Pfizer Inc
Purchase $1,001 - $15,000
Jan 08, 2024 Dec 20, 2023 -32.38%
Congress pfp
Shelley Moore Capito R / Senate
PFE logo
PFE Pfizer Inc
Sale (Partial) $1,001 - $15,000
Jan 12, 2024 Dec 18, 2023 -29.29%
Congress pfp
Jerry Moran R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Sale (Full) $1,001 - $15,000
Jan 17, 2024 Dec 14, 2023 -26.83%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $15,001 - $50,000
Jan 12, 2024 Dec 12, 2023 -35.95%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -35.95%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jan 12, 2024 Dec 12, 2023 -35.95%
Congress pfp
Sheldon Whitehouse D / Senate
PFE logo
PFE Pfizer Inc
Sale (Full) $1,001 - $15,000
Jan 18, 2024 Dec 11, 2023 -36.67%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Dec 18, 2023 Dec 08, 2023 +1.46%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV Abbvie Inc
Sale (Full) $1,001 - $15,000
Dec 15, 2023 Nov 20, 2023 +9.15%
Congress pfp
John James R / House
ABBV logo
ABBV ABBVIE INC. COMMON STOCK
Purchase $1,001 - $15,000
Sep 02, 2024 Nov 10, 2023 +5.30%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Dec 08, 2023 Nov 08, 2023 +1.33%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -51.57%
Congress pfp
Greg Stanton D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -6.10%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -23.91%
Congress pfp
Tommy Tuberville R / Senate
ABBV logo
ABBV AbbVie Inc. Common Stock
Purchase $1,001 - $15,000
Nov 16, 2023 Oct 17, 2023 -4.84%
Congress pfp
Robert J. Wittman R / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Oct 19, 2023 Sep 28, 2023 -9.31%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -20.14%
Congress pfp
Greg Stanton D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -10.81%
Congress pfp
Greg Stanton D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -54.87%
Congress pfp
Scott Franklin R / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 12, 2023 Sep 11, 2023 -52.20%
Congress pfp
Lois Frankel D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -53.56%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Oct 10, 2023 Sep 08, 2023 -2.12%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Oct 10, 2023 Sep 06, 2023 +0.79%
Congress pfp
Jared Moskowitz D / House
PFE logo
PFE PFIZER, INC. COMMON STOCK
Sale $1,001 - $15,000
Aug 21, 2024 Sep 01, 2023 -54.81%
Congress pfp
Lois Frankel D / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Oct 10, 2023 Aug 30, 2023 -0.15%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC.
Sale $15,001 - $50,000
Sep 05, 2023 Aug 14, 2023 -3.92%
Congress pfp
Michael Guest R / House
ABBV logo
ABBV ABBVIE INC.
Purchase $1,001 - $15,000
Aug 23, 2023 Aug 07, 2023 -1.79%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Aug 21, 2023 Jul 27, 2023 -0.15%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Aug 14, 2023 Jul 25, 2023 -55.87%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 21, 2024 Jul 14, 2023 +4.69%
Congress pfp
Daniel S. Goldman D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Aug 13, 2023 Jul 14, 2023 +9.96%
Congress pfp
Daniel S. Goldman D / House
ABBV logo
ABBV ABBVIE INC.
Sale $50,001 - $100,000
Aug 13, 2023 Jul 12, 2023 +10.07%
Congress pfp
Daniel S. Goldman D / House
PFE logo
PFE PFIZER, INC.
Sale $15,001 - $50,000
Aug 13, 2023 Jul 12, 2023 -56.58%
Congress pfp
Michael C. Burgess R / House
ABBV logo
ABBV ABBVIE INC.
Purchase $15,001 - $50,000
Jul 18, 2023 Jul 06, 2023 +6.21%
Congress pfp
Lois Frankel D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
Jul 28, 2023 Jun 28, 2023 -59.20%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Jul 11, 2023 Jun 26, 2023 +6.59%
Congress pfp
Tommy Tuberville R / Senate
PFE logo
PFE Pfizer, Inc. Common Stock
Purchase $1,001 - $15,000
Jul 14, 2023 Jun 12, 2023 -65.89%
Congress pfp
Shelley Moore Capito R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $1,001 - $15,000
Jul 17, 2023 Jun 12, 2023 +6.19%
Congress pfp
Zoe Lofgren D / House
PFE logo
PFE PFIZER, INC.
Sale $1,001 - $15,000
Jun 06, 2023 May 26, 2023 -66.52%
Congress pfp
Zoe Lofgren D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Jun 06, 2023 May 26, 2023 +0.35%
Congress pfp
Josh Gottheimer D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
Jun 11, 2023 May 19, 2023 -6.62%
Congress pfp
Josh Gottheimer D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Jun 11, 2023 May 01, 2023 -10.68%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -12.19%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -12.19%
Congress pfp
Kathy E. Manning D / House
ABBV logo
ABBV ABBVIE INC.
Sale $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -12.19%
Congress pfp
Kathy E. Manning D / House
PFE logo
PFE PFIZER, INC.
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -69.73%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
May 19, 2023 Apr 28, 2023 -11.00%